INS and diabetes mellitus: Our aim was not only to describe our clinical experience with CIPII, but also to highlight the need for this insulin delivery system to remain available for centers of excellence, combined with stable availability of compatible human insulin, and to establish a path for accessing this technology even for more peripheral diabetes centers.